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DETECTING DOWN SYNDROME AMONG A HIGH RISK POPULATION
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Ashley Marie Henriksen
Supervisory Professor: Jennifer Hoskovec M.S., C.G.C

The purpose of this study was to determine the perception and knowledge of targeted
ultrasound in women who screen positive for Down syndrome in the first or second
trimester, and to assess the perceived detection rate of Down syndrome by targeted
ultrasound in this population. While several studies have reported patient perceptions’ of
routine ultrasound, no study has specifically examined knowledge regarding the targeted
ultrasound and its role in detecting Down syndrome. A targeted ultrasound is a special
ultrasound during the second trimester offered to women who may be at a higher-thanaverage risk of having a baby with some type of birth defect or complication. The purpose of
the ultrasound is to evaluate the overall growth and development of the baby as well as
screen for birth defects and genetic conditions. Women under the age of 35 referred for an
abnormal first or second trimester maternal serum screen to several Houston area clinics
were asked to complete a questionnaire to obtain demographic and ultrasound knowledge
information as well as assess perceived detection rate of Down syndrome by ultrasound.
Seventy-seven women completed the questionnaire and participated in the study.
Our findings revealed that women have limited background knowledge about the
targeted ultrasound and its role in detecting Down syndrome. These findings are consistent
with other studies that have reported a lack of understanding about the purpose of ultrasound
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examinations. One factor that seems to increase background knowledge about the targeted
ultrasound is individuals having a higher level of education. However, most participants
regardless of race, education, income, and exposure to targeted ultrasound information did
not know the capabilities of a targeted ultrasound.
This study confirmed women lack background knowledge about the targeted
ultrasound and do not know enough about the technology to form a perception regarding its
ability to detect Down syndrome. Additional studies to identify appropriate education
techniques are necessary to determine how to best inform our patient population about
targeted ultrasound.
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BACKGROUND

Introduction
Prenatal diagnosis of chromosome abnormalities has become increasingly more
common with the delay of childbearing in women into their mid to late thirties and early
forties (Milunsky & Milunsky, 2010). Due to the associated risk of miscarriage with
prenatal diagnostic procedures, the risk for fetal loss is increasingly regarded as
unacceptable. Researchers strive to develop techniques that optimize selection of
pregnancies warranting invasive testing to decrease procedure-related losses of normal
fetuses (Yeo & Vintzileos, 2003). The goal of targeted sonography is to evaluate for midtrimester markers allowing the practitioner to adjust the risk of fetal aneuploidy (BahadoSingh, Oz, Mendilcioglu, & Mahoney, 2005). Due to varied midtrimester presentation,
maternal body habitus, ultrasonographic markers, operator proficiency, and available
equipment, detection rate of fetal aneuploidy by ultrasound, primarily trisomy 21, is
dependent on several factors and the efficacy is controversial. Genetic counseling is an
important step in educating patients on the benefits, risks and limitations of ultrasound. The
purpose of this study is to determine perception and knowledge of targeted ultrasound in
women who screen positive for Down syndrome in the first or second trimester and to assess
the perceived detection rate of Down syndrome by targeted ultrasound in this population.

Down Syndrome
Down syndrome is one of the most common genetic conditions and occurs with a
frequency of 1 in 800 live births per year in the United States (Nussbaum, McInnes, Willard,
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Thompson, & Hamosh, 2007). Individuals with Down syndrome have some degree of
mental retardation and characteristic facial features. Health concerns among individuals
with Down syndrome are more frequent than that in the general population, although
severity and frequency are variable (March of Dimes, 2009).
The increased health problems and mental retardation are due to an extra copy of
chromosome 21. Forty-four percent of individuals with Down syndrome have a congenital
heart defect, most commonly atrioventricular septal defect, secundum atrial septal defect,
and ventral septal defect (Freeman et al., 2008). Seventy-five percent will have some form
of hearing loss, and there is a high incidence of otitis media (50-70%) and eye disease (60%)
as well. Additional health conditions may include Hirschsprung disease, leukemia, sleep
apnea, congenital hypothyroidism and an increased incidence of early onset Alzheimer
disease ("American Academy of Pediatrics: Health supervision for children with Down
syndrome," 2001; Tyrrell et al., 2001). The degree of mental retardation is variable ranging
from mild (Intellectual Quotient (IQ) 50-70) to moderate (IQ 35-50), and in rare cases,
severe mental impairment may occur (IQ 20-35) ("American Academy of Pediatrics: Health
supervision for children with Down syndrome," 2001).
An association between maternal age and an increased risk for Down syndrome is
well established. Advanced maternal age is defined as a woman who is 35 years of age or
older at the time of delivery. The mid-trimester risk for Down syndrome for a 35-year-old
woman is 1 in 250 (Hook, 1981). Traditionally, women of advanced maternal age are
considered at “high risk,” and those below this threshold are considered “low risk”
(Bromley, Lieberman, Shipp, & Benacerraf, 2002). Although the risk for Down syndrome
increases with maternal age, 80% of infants born with Down syndrome are born to mothers
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under the age of 35, as women in this age group have a higher frequency of births in general
(National Down Syndrome Congress, 2010). Maternal age as a screening method currently
identifies only about 47% of trisomy 21 cases and is associated with a high false-positive
rate (12%-13%) (Egan et al., 2000). For these reasons, maternal age alone is not the most
optimal screening tool (Driscoll & Gross, 2009). Maternal serum screening is often utilized
to categorize women under the age of 35 years whose pregnancies are at an increased risk
for Down syndrome; moving them from a low risk to a high risk category.

Prenatal Screening
The association between maternal age and incidence of Down syndrome has
triggered the use of prenatal serum screening and diagnostic testing to identify pregnancies
at higher risk for karyotypic abnormalities. Currently, the American College of
Obstetricians and Gynecologists (ACOG) recommends that all women, regardless of age, be
offered screening tests for aneuploidy prior to 20 weeks gestation ("ACOG Practice Bulletin
No. 77: Screening for fetal chromosomal abnormalities," 2007). Maternal serum screening,
apart from maternal age, is the only screening method for Down syndrome and may be
performed in the first or second trimester ("ACOG Educational Bulletin. Maternal serum
screening," 1996). First trimester screening is performed between 11 and 14 weeks
gestation and consists of a sonographically obtained nuchal translucency measurement
combined with maternal serum free beta human chorionic gonadotropin (hCG) and
pregnancy-associated plasma protein-A (PAPP-A) measurements and maternal age (March
of Dimes, 2008). The detection rate for Down syndrome by first trimester screening ranges
from 82% to 87% ("ACOG Practice Bulletin No. 77: Screening for fetal chromosomal
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abnormalities," 2007). Second trimester screening tests are performed between 15 and 20
weeks gestation (March of Dimes, 2008). These tests include triple (maternal serum alphafetoprotein (MSAFP), hCG, and unconjugated estriol), quadruple (includes inhibin A in
addition to triple markers), or penta (includes invasive trophoblast antigen or ITA) marker
screening in conjunction with maternal age. The detection rates for Down syndrome by
these screening tests are 69%, 81%, and 83%, respectively ("ACOG Practice Bulletin No.
77: Screening for fetal chromosomal abnormalities," 2007; Palomaki, Neveux, Knight,
Haddow, & Pandian, 2004). It is essential for patients to understand the difference between
a screening test and a definitive diagnostic test with its associated risks, and the benefits and
limitations of each procedure.

Diagnostic Tests
Invasive testing for prenatal diagnosis includes chorionic villus sampling (CVS),
offered between 10 and 13 weeks-gestation, amniocentesis, offered after 15 weeks-gestation,
and fetal blood sampling. The risk for miscarriage due to CVS is approximately 0.5% to 1%,
while the average risk associated with amniocentesis is 0.25% to 0.5% ("Chorionic villus
sampling and amniocentesis: recommendations for prenatal counseling. Centers for Disease
Control and Prevention," 1995). More recently, ACOG reports the procedure-related risk
with amniocentesis as being between 0.2% to 0.33% ("ACOG Practice Bulletin No. 88,
December 2007. Invasive prenatal testing for aneuploidy," 2007).
Prior to 2007, ACOG only recommended offering diagnostic testing to women of
advanced maternal age, or those considered at increased risk due to abnormal serum screen
results, due to the procedural risk for miscarriage ("ACOG Practice Bulletin No. 77:
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Screening for fetal chromosomal abnormalities," 2007). ACOG now recommends that all
pregnant women should have the option of diagnostic testing in addition to, or in lieu of,
screening regardless of age or screening results ("ACOG Practice Bulletin No. 77: Screening
for fetal chromosomal abnormalities," 2007). Prior to the 1950’s, amniocentesis was
indicated for the treatment of hydramnios during pregnancy. It was also used to localize the
placenta by contrast media injection, during pregnancy termination by injection of
hypertonic saline, and for monitoring of fetuses with Rh isoimmunization. Since that time,
advancements in prenatal diagnosis have allowed for prenatal detection of chromosome
disorders and other genetic conditions via traditional amniocentesis and chorionic villus
sampling (Milunsky & Milunsky, 2010). Early amniocentesis, performed prior to 15 weeks
gestation, is not offered clinically on a regular basis unless a lethal anomaly is suspected due
to incomplete fusion of amniotic and chorionic membranes, a higher rate of spontaneous
pregnancy loss and an increased rate of talipes equinovarus (Milunsky & Milunsky, 2010).
Because the majority of pregnancies subjected to the miscarriage risks associated
with invasive testing are chromosomally normal, the risk for fetal loss is increasingly
regarded as unacceptable. There is a rising demand for the combined evaluation of maternal
age, maternal serum screening, and ultrasound findings to determine individualized patient
risk estimates to more accurately identify pregnancies warranting invasive testing
(Breathnach, Fleming, & Malone, 2007).

Ultrasound Technology
Ultrasound is a significant advancement in prenatal diagnosis and management.
Prenatal sonographic imaging continues to improve and has become a widely used screening
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tool for pregnant women, including those at low risk (Verrotti, Caforio, Gramellini, &
Nardelli, 2007). Approximately 70% of pregnant women in the United States have an
ultrasound exam at least once during pregnancy (Martin et al., 2003).
Ultrasound was introduced as a diagnostic tool in medicine in the early 1940’s. Prior
to 1975, ultrasound was used in obstetric medicine for biparietal diameter, determination of
amniotic fluid volume, evaluation of singleton or multiple gestations, intrauterine fetal
death, and placental location. The first real-time scanners were developed in the late 1960’s
enabling visualization of fetal movement and more accurate diagnosis of several fetal
abnormalities. Malformations including anencephaly, duodenal atresia, hydrops fetalis,
bone dysplasias, hydrocephalus, and polycystic kidneys were clearly diagnosed via
ultrasound by the early 1980’s. With improvements in technology, including high resolution
scanners, the diagnosis of spina bifida and other more subtle abnormalities, such as cardiac
defects, became possible. Current technology allows diagnosis of fetal anomalies earlier in
gestation; moving prenatal diagnosis from the third trimester to the second, and sometimes
to the first trimester. With current ultrasound equipment, sonographers and sonologists are
capable of identifying minor fetal abnormalities and normal variants known as soft signs or
soft markers associated with chromosome abnormalities (Woo, 2001).
Ultrasound technology continues to evolve and improve supporting more accurate
fetal observation and diagnosis. Color flow Doppler and power Doppler imaging were
developed to examine fetal circulation and measure fetal, placental, and umbilical cord
blood flow velocities. Introduction of three-dimensional ultrasound provides additional scan
planes to better evaluate fetal anomalies, particularly after post processing analysis. One of
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the greatest advantages to this technology is its acceptance as a low-risk modality (Twining,
2000).
In general, ultrasound is a noninvasive, sound wave imaging tool generated by a
transducer attached to a hand-held probe. The most advanced ultrasound technology
employs a method using synthetic crystals (zirconate) to provide low-energy, highfrequency sound waves. Waves of low and high pressure vibrations are created and
transmitted into the tissue. In order to obtain the image, a coupling gel is applied to the
transducer to decrease the loss of sound waves at the skin-transducer interface. The gel
eliminates air between the probe and surface of skin. The waves reflect off of fetal and
maternal tissues and are detected by the emitting transducer. The image produced is
displayed on a screen corresponding to the intensity of the echo. There are 128 intensity or
brightness shades shown on a gray scale. Blood, amniotic fluid, and urine appear black on
the ultrasound screen as sound waves pass through liquid and do not reflect back. Denser
tissues, such as bone, absorb the sound wave and appear white or echogenic. Soft tissues
appear as shades of gray depending on the density. The resulting image is also dependent on
the time lag of the returning echo. The majority of diagnostic ultrasounds today operate by a
phased array real-time technology. Motion of the target structure, as seen in real-time
ultrasonography, is possible due to sequential firing of multiple crystals. This allows
ultrasound waves to emit and receive fast enough to detect movement (Creasy & Resnik,
1994; Cunningham & Williams, 2001).
There are four distinct types of ultrasound examinations as defined by ACOG. First
trimester ultrasound is performed prior to 13 weeks and 6 days gestation and primarily
confirms intrauterine pregnancy viability, gestational age, and diagnosis of multiple
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gestations. Additionally, first trimester ultrasounds are utilized for nuchal translucency
measurements for first trimester aneuploidy screening. The standard obstetric ultrasound
exam is performed during the second or third trimester and evaluates fetal presentation,
volume of amniotic fluid, cardiac activity, placental position, fetal number, and basic fetal
anatomy. A limited ultrasound examination is used to assess a specific question, such as
confirming fetal heart rate or placental location and is usually performed after a standard
exam is on file. Finally, the specialized exam, also known as the targeted ultrasound, is
similar to the standard obstetric ultrasound but assesses fetal anatomy in detail and is often
performed when an anomaly is suspected ("ACOG Practice Bulletin No. 101:
Ultrasonography in pregnancy," 2009).
Ultrasound is a screening tool limited primarily by gestational age and technology
(Bofill & Sharp, 1998). Bofill and Sharp (1998) describe two of the pitfalls associated with
antenatal sonograms: misdiagnosis and missed diagnosis. Misdiagnosis is a false-positive
scan and often corrected by a follow-up, more detailed sonogram performed at a tertiary care
center. A missed diagnosis, or false-negative scan, will not be detected unless further
examination is pursued for an additional indication.
Women with certain indications, or high risk populations, are referred for targeted
sonograms which are ideally performed during the second trimester. Indications for a
targeted ultrasound include abnormalities in amniotic fluid volume, abnormal maternal
serum screen results, advanced maternal age, family or personal history of a chromosome
abnormality or birth defect, teratogen exposure, structural anomalies identified on prior
obstetrical scan, or maternal illness (Bofill & Sharp, 1998). Among high risk populations,
the term “genetic sonogram” evolved to describe the application of the targeted, second
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trimester ultrasound to adjust the risk for chromosomal aneuploidy (Breathnach et al., 2007).
Both structural anomalies and sonographic markers, or soft signs, are used to evaluate the
risk for aneuploidy.
The use of ultrasound in prenatal diagnosis for structural malformations is highly
dependent on operator expertise. Structural malformations frequently identified in
specialized centers include: central nervous system abnormalities such as anencephaly, spina
bifida, and hydrocephalus, skeletal defects, and internal organ abnormalities. Detection of
internal abnormalities such as congenital heart defects, renal anomalies, obstructive
uropathy, abdominal wall defects, and fetal tumors, often depends on severity (Harper,
2004). As ultrasound is often most useful when interpreted in conjunction with other
appropriate studies, further testing options should be considered in the context of suspected
malformations.

Sonographic Findings for Down Syndrome
Both structural anomalies and soft sonographic markers can be combined to increase
detection of chromosomal aneuploidy in a fetus. Unlike structural anomalies, soft markers
are often clinically insignificant in isolation and may resolve over time. When screening for
Down syndrome, the most common structural anomalies detected include cardiac defects,
duodenal atresia, and cystic hygroma. Although it is possible to detect structural
abnormalities in the late first trimester and early second trimester (Nyberg & Souter, 2001),
most anomalies are not identified until further in gestation. Second trimester sonographic
markers for Down syndrome include nuchal fold thickening, ventriculomegaly, short long

9

bones, echogenic bowel, pyelectasis, intracardiac echogenic focus, and hypoplastic nasal
bone (Breathnach et al., 2007).
A fetus with trisomy 21 may not show structural abnormalities prior to 20 weeks
(Nyberg & Souter, 2001). In a study performed by Nyberg and colleagues, major
abnormalities were detected in 16.7% of fetuses with Down syndrome prior to 20 weeks
gestation. This group excluded patients specifically referred for an identified structural
malformation (Nyberg et al., 2001). Nearly 50% of babies with Down syndrome are born
with a congenital heart defect (Freeman et al., 2008). Detecting heart defects by ultrasound
depends on the type and severity of the defect and gestational age at the time of exam.
Cardiac abnormalities are not readily identified at earlier gestational ages. An additional
study of women at a mean gestational age of 16.9 weeks by Nyberg and colleagues
consistently identified cardiac defects in less than 10% of fetuses with trisomy 21 (Nyberg
& Souter, 2001). A comparable study evaluated women sonographically at a mean
gestational age of 18 weeks with real-time and color Doppler ultrasound. Findings included
structural and functional cardiac findings, such as ventral septal defects, outflow tract
abnormalities, right-left disproportion, pericardial effusion, and tricuspid regurgitation.
Seventy six percent of trisomy 21 fetuses had a heart finding, and only 9% were endocardial
cushion defects. Although the study concentrated on heart findings associated with Down
syndrome, multiple markers were evaluated. Excluding structural heart defects, the
detection rate for Down syndrome was 60% but increased to 91% with inclusion of heart
abnormalities. Therefore, identification of congenital cardiac defects is a major contributor
to increased detection rate of Down syndrome by ultrasound (DeVore, 2000). Paladini and
coworkers scanned 41 fetuses with a diagnosis of trisomy 21 at an average of 24 weeks in
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pregnancy. With knowledge of fetal karyotype and at the optimal gestational age, about
50% of fetuses with Down syndrome studied had a detectable heart defect (Paladini et al.,
2000). Other studies have reported higher detection of major malformations but often
include patients referred for a previously identified anomaly which increases their detection
rate.
Nyberg and collaborators reviewed common sonographic markers used to estimate
risk of Down syndrome. Nuchal thickening refers to redundant skin at the back of the fetal
neck. A measurement of 6 mm or greater after 15 weeks indicates an increased risk for
trisomy 21 (Benacerraf, Frigoletto, & Laboda, 1985). Several studies, including the authors,
use a cutoff of 5 mm at less than 20 weeks to increase detection and it only slightly increases
the false-positive rate (Nyberg & Souter, 2001).
Hyperechoic bowel is often a benign finding but has shown an association with fetal
aneuploidy defining it as a soft marker. A grading system is used to evaluate echogenic
bowel. Grade 1 is mildly echogenic and often diffuse, grade 2 is moderately echogenic and
typically focal, and grade 3 is very echogenic, as bright as bone. The authors consider both
moderate and markedly hyperechoic bowel a risk factor for Down syndrome (Nyberg &
Souter, 2001).
Generally, the size of the lateral cerebral ventricles does not change throughout
gestation. The diameter measures 6.1 mm and varies slightly between male and female
fetuses. Typically, males have larger ventricles than females (Patel, Goldstein, Tung, &
Filly, 1995). Ventriculomegaly is defined when lateral ventricles measure 10 mm or greater.
Mild ventriculomegaly is considered a minor marker for Down syndrome as it is often
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transient and nonspecific, as well as a common characteristic identified in normal fetuses
(Nyberg & Souter, 2001).
Short stature is a common feature in individuals with Down syndrome and is
attributed to disproportionately short long bones: femur and humerus. Shortening of these
bones can be detected prenatally. Measurements are evaluated by comparing the actual
length with the expected length, typically based on biparietal diameter or a similar dating
measurement as opposed to gestational age. Historically, single cutoff values were used for
shortened femur and shortened humerus: 0.91 multiples of the median for short femur and
0.89 for short humerus (Nyberg & Souter, 2001). Recently, measurements of the long bones
have been converted to expected multiple of the median data and calculated likelihood ratios
rather than a universal cutoff (Bahado-Singh, Oz, Gomez et al., 1998).
Mild pyelectasis is most commonly seen in normal fetuses but shows an association
with aneuploidy. Pyelectasis is defined as a measurement of the fluid-filled renal pelvis in
an anteroposterior diameter above 4 mm in the mid-trimester (Nyberg & Souter, 2001).
The final common sonographic marker for Down syndrome is intracardiac echogenic
foci (ICEF). ICEF refers to papillary muscle calcifications detected on ultrasound (Nyberg
& Souter, 2001). Shipp et al. (Shipp, Bromley, Lieberman, & Benacerraf, 2000) found
ICEF more common among Asian patients compared to Caucasian. Understanding the
increased frequency in specific populations affects risk assessments for women with an
identified ICEF (Nyberg & Souter, 2001).
Additional skeletal findings may be evaluated during ultrasound including
clinodactyly (shortened middle phalanx of the fifth finger) and widened pelvic angle. These
features are seen in some individuals with Down syndrome; however, both measurements
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are difficult to assess by ultrasound and are often not included as screening markers (Nyberg
& Souter, 2001). Absence of nasal bone is used in some centers.
Individual detection of soft markers varies by location, timing, and specific finding.
Hobbins et al. (2003) evaluated a subgroup of 176 Down syndrome cases from a multicenter study referred during mid-trimester for advanced maternal age or an abnormal triple
screen. This group evaluated the following sonographic markers shortened femur and
humerus, increased nuchal skin thickness, pyelectasis, echogenic intracardiac focus,
hypoplastic fifth digit, sandal gap toe, echogenic bowel, and the presence of major
anatomical defects. Nuchal thickness had the highest sensitivity for detecting Down
syndrome (36.5%). The sensitivity for other observed soft markers was short femur
(20.6%), short humerus (20.6%), echogenic intracardiac focus (21.3%), pyelectasis (17.2%),
hypoplastic fifth digit (18.9%), echogenic bowel (13.5%), and sandal gap toe (3%). The
false-positive rates for this study were not reported. Interestingly, the sensitivity for AMA
cases was reported as 70.8% (95/134) with varying estimates from 40-100%. Comparably,
among the positive triple marker screen population, the sensitivity for Down syndrome was
71.4% (Hobbins et al., 2003).
Studies have also gathered information to calculate likelihood ratios
(sensitivity/false-positive rate) of sonographic findings for fetal Down syndrome. The
likelihood ratio for each soft marker reflects the associated risk for Down syndrome. Ageadjusted sonographic risk assessment includes the risk of the identified ultrasound findings
by using the likelihood ratio (LR). The following table is data from Nyberg et al. (2001).
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LR for Marker as
95% Confidence
Interval
an Isolated Finding
Nuchal thickening
61
11
5.5-22
Hyperechoic bowel
33.8
6.7
2.7-16.8
Short humerus
15.3
5.1
1.6-16.5
Short femur
6.1
1.5
0.8-2.8
Echogenic intracardiac focus
6.3
1.8
1.0-3.2
Pyelectasis
5.2
1.5
0.6-3.6
Reprinted with Permission from the American Institute of Ultrasound in Medicine
Sonographic Marker

LR Overall

Smith-Bindman and colleagues determined likelihood ratios for sonographic markers and
calculated similar values as Nyberg et al. (2001) and found the greatest likelihood ratio
associated with nuchal thickening (LR=17). They concluded that as isolated findings, a
second-trimester ultrasound soft marker is not useful in confirming or excluding the
possibility of Down syndrome. Nuchal thickening is the only significant marker that may
help to differentiate a fetus affected or unaffected (Smith-Bindman, Hosmer, Feldstein,
Deeks, & Goldberg, 2001).
Sonographic soft markers in general appear more frequently among fetuses with a
chromosomal anomaly compared to unaffected fetuses. Viora et al. reported a prevalence of
soft markers in 70% of trisomy 21 cases compared to 28% of cases with normal karyotypes.
They concluded that the clinical use of ultrasound in identifying pregnancies at risk for
trisomy 21 using soft markers is limited by the high false-positive rate and low sensitivity
(Viora, Errante, Bastonero, Sciarrone, & Campogrande, 2001). A meta-analysis of
ultrasound markers in the mid-trimester to determine the accuracy of detecting Down
syndrome prenatally produced similar results. A total of 56 articles were reviewed that
included 1,930 cases of Down syndrome and 130,365 unaffected cases. The majority of the
studies (88%) included women at high risk for chromosome abnormalities due to age, serum
screening results, or a significant family history. Results showed that the sensitivity and
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specificity for the detection rate of Down syndrome among the studies was highly variable.
For example, the sensitivity for detecting fetuses with Down syndrome based on increased
nuchal fold measurements ranged from 7% to 75%. The group determined two reasons for
the heterogenous results. One, the accuracy of the studies was inconsistent based on the
study design. There was a significant difference between studies performed by case-control
or prospective methods. Second, sensitivity and specificity varied dependent on whether the
marker was seen in isolation or with an associated structural anomaly. Studies evaluating
Down syndrome risk based on isolated soft markers reported significantly lower sensitivities
ranging from 1% for choroid plexus cysts to 16% for shortened femur. The review
concluded that accuracy for most sonographic markers for Down syndrome is poor, but it
remains common practice among clinicians to adjust risk for trisomy 21 based on these
findings (Smith-Bindman et al., 2001).

Detection Rate of Down Syndrome by Ultrasound
As discussed, genetic sonography is the systematic use of multiple mid-trimester
markers to adjust the risk of fetal aneuploidy. This type of ultrasound is historically used
among high-risk pregnancies. While the frequency of major structural anomalies is much
higher in trisomies 18 and 13 and ultrasound has a high sensitivity in detecting them (83100% for trisomy 18 and 91% for trisomy 13), similar evidence for the effectiveness of
identifying Down syndrome varies (Lehman et al., 1995; Nyberg et al., 1993). A review of
literature revealed about 25% of second trimester fetuses with Down syndrome have
distinctive ultrasound findings or structural malformations. Investigators have incorporated
other soft markers to increase the sensitivity of ultrasound in the detection of Down
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syndrome (Vintzileos & Egan, 1995). In addition, integrating ultrasound findings with other
screening methods (i.e. biochemical serum markers and maternal age) increases the
sensitivity for detecting Down syndrome (Bahado-Singh et al., 2005). For the purpose of
this study, the value assigned to a positive genetic sonogram will be referred to as the
detection rate of Down syndrome by ultrasound.
The detection rate of Down syndrome by ultrasound remains controversial and is
variable. Quality of ultrasound equipment, technologist expertise, gestational age, maternal
body habitus, fetal position, and the use of soft markers all play a role in the reported
sensitivity. ACOG cites studies reporting a detection of malformations or soft markers
suggestive of Down syndrome in approximately 50-75% of pregnancies during the second
trimester but does not recommend using ultrasonography as a primary screening tool for
Down syndrome due to its limitations ("ACOG Practice Bulletin No. 101: Ultrasonography
in pregnancy," 2009). Although the sensitivity of screening methods does not match that of
diagnostic testing options, the practice of offering routine invasive testing to all high risk
pregnant women has been challenged due to the associated miscarriage risks. Efforts to
improve sensitivity and specificity of screening tools are rapidly underway to minimize the
number of women subjected to this risk. When advanced maternal age alone is used to
categorize women into low and high risk, about 140 amniocenteses are required to identify
one fetus with Down syndrome. When incorporating triple marker screening 60
amniocenteses are needed to detect one fetus with Down syndrome (Vintzileos & Egan,
1995). Using the definition of an abnormal genetic sonogram, Yeo and Vintzileos (2003)
reviewed the accuracy of second-trimester genetic sonography for the detection of Down
syndrome among several institutions. The overall sensitivity of the genetic sonogram was
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77% and the false-positive rate was 13%. Vintzileos et al. (1996) reported a sensitivity of
93% (13/14) and a false-positive rate of 13% (54/406). Nyberg and coworkers evaluated
142 consecutive fetuses with trisomy 21 in the second trimester for nuchal thickening,
echogenic bowel, shortened femur, shortened humerus, renal pyelectasis, and ‘structural’
abnormalities. The group published a sensitivity of 68.3% (97/142) and false-positive rate of
12.5% (116/930) for Down syndrome (Nyberg, Luthy, Resta, Nyberg, & Williams, 1998).
Bromley et al. (1997) contributed to the literature with a reported sensitivity of 83% (44/53)
and 17.5% false-positive rate (31/177) for the sonographic detection of Down syndrome.
Using a similar panel of six ultrasound markers, one study found one or more abnormalities
in 50% of pregnancies with Down syndrome (Nyberg et al., 1995). The variation between
centers is a valid concern of ultrasound screening for Down syndrome. Based on the above
criteria, any positive ultrasound finding increases the risk for aneuploidy. Many of the
criteria used to evaluate the risk of trisomy 21 depend on measurements that reach a certain
threshold. This becomes particularly sensitive within and between centers when
measurements are of borderline significance. Small discrepancies in measurement can
largely affect the risk assessment (Nyberg et al., 1998).
Of equal importance, a normal ultrasound scan can reduce the risk of Down
syndrome when properly evaluated. According to Nyberg et al. (1998), a negative scan
following a positive biochemical serum screen reduces the risk of Down syndrome by
approximately 60%. A more recent study determined the likelihood of fetal trisomy 21 was
reduced by 83-89% following a normal genetic sonogram (Vintzileos et al., 2002). Yeo and
Vintzileos (2003) adjusted the risk for fetal trisomy 21 based on their own center’s accuracy.
The patient’s a priori risk was multiplied by various likelihood ratios depending on the
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presence or absence of specific ultrasound findings. For example, a patient beginning with a
maternal age risk of 1:274 with a normal genetic sonogram has an adjusted risk for fetal
trisomy 21 of 1:1370 (1:274 multiplied by 0.20) due to at least an 80% reduction in risk.
Each center uses its own likelihood ratios and is still limited by operator error.
Attempts have been made to integrate the information from sonography into
clinically useful risk assessment models for Down syndrome. Benacerraf and colleagues
created a genetic sonogram scoring index for this purpose. In 1992, the scoring index
proposed optimized the detection rate of Down syndrome among fetuses in mothers of any
age. Each fetus was assessed for the presence of a nuchal fold greater than or equal to 6
mm, shortened femur and/or humerus, and pyelectasis. Structural malformations evaluated
in the study included ventriculomegaly, heart defects, and limb abnormalities. The original
scoring algorithm assigned major anomalies and thickened nuchal fold a value of 2 and all
other soft markers were scored as a value of 1. Using a score of greater than or equal to 2 as
a positive test, the results yielded an 81% detection rate and 4.4% false-positive rate
(Benacerraf, Neuberg, Bromley, & Frigoletto, 1992).
Bromley and colleagues modified the scoring index by incorporating maternal age as
a risk factor and also incorporated additional soft markers: echogenic intracardiac focus and
hyperechoic bowel. Maternal age was divided into 3 categories, < 35 years, 35 to 39 years,
and ≥ 40 years; each group with a corresponding score of 0, 1, and 2 respectively. The soft
markers were assigned a value of 1. The study concluded that women < 35 years old
received a positive score solely based on ultrasound markers. Patients between 35 and 39
years of age contributed a score of 1 based on age alone and only needed one additional
ultrasound finding to receive a positive test. Finally, all women ≥ 40 years old automatically
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scored positive based on age alone. Using the modified algorithm with maternal age,
sensitivity for Down syndrome was 86.8% but a false positive rate of 27.1 % was reported
(Bromley et al., 1997).
In an effort to create a more accurate algorithm, Bahado-Singh and colleagues
introduced a technique to modify the previous dichotomous variables of “normal” and
“abnormal” to a continuous mathematical variable for the biometric marker information.
Their method involved standardizing the ultrasound measurements (i.e. nuchal thickness and
humerus length) to minimize errors due to gestational age calculations. Using the same
concept as serum marker value conversions, the standardized values were changed to
multiples of the medians to allow the development of Gaussian distribution curves for the
measurements in both Down syndrome and normal mid-trimester fetal groups (BahadoSingh, Deren, Oz et al., 1998). This technique further individualized the risk of Down
syndrome for a woman based on maternal age, biometric parameters, and serum markers.
Using independent predictors of Down syndrome, Bahado-Singh and collaborators (2000)
further evaluated their algorithm among a high-risk group of women consisting of 46 Down
syndrome and 2,391 unaffected cases. Using maternal age, nuchal thickness, humerus
length, serum AFP and hCG, researchers reported a sensitivity of 80.4% and 10% falsepositive rate for Down syndrome.
In contrast to ultrasound screening in high-risk populations, the benefits of routine
ultrasound screening in the general population have not been appropriately determined.
According to Bahado-Singh et al. (2005), “There is a near complete absence of appropriately
designed, prospective population-based ultrasound studies” (Bahado-Singh et al., 2005).
Among the few studies, Shirley et al. (1992) used a hospital based population in the United
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Kingdom for a mid-trimester ultrasound screening program. Six thousand one hundred
eighty-three cases between 1989 and 1990 underwent routine ultrasound at an average of 19
weeks gestation. There were 10 confirmed cases of Down syndrome, of which 3 (30%) had
an abnormal ultrasound before 22 weeks gestation. Six had no detectable anatomical
malformations. The remaining case appeared normal at the 19 week scan but was diagnosed
by karyotype during the third trimester secondary to fetal hydrops. The exam included
evaluation of gross defects, nuchal skin thickness, renal pelvis, and ventriculomegaly.
Jorgensen et al. (1999) performed a multi-center Scandinavian second-trimester ultrasound
screening study of 27,844 low-risk women between the ages of 18 and 34 years. The group
was evaluated for gross defects, femur length shortening and nuchal thickness. Among 32
cases of Down syndrome, 6.3% were detected by ultrasound. A retrospective study by
Howe et al. (2000) reviewed 31,259 pregnancies in a maternity unit in the UK between 1993
and 1998. The overall detection rate of Down syndrome by routine ultrasonography was
68%. The detection rate among women less than 35 years of age was 53% (9/17). The
study did not clearly define thresholds used for detection. A similar study of 36,410 women
of average age 27 years underwent mid-trimester serum screen and ultrasound between 18
and 22 weeks. Among 24,276 screen-negative cases, twenty percent (2/10) Down syndrome
fetuses had sonographic abnormalities. Nine thousand nine hundred and sixty study
participants declined serum screening; sonographic abnormalities were detected in 4/7
(57%) of fetuses with Down syndrome. The detection of Down syndrome increased by 11%
when mid-trimester ultrasounds were compared to serum AFP and hCG screening alone.
The study included several soft markers including pyelectasis, bowel echogenicity,
shortened long bones, ventriculomegaly, nuchal thickness, and choroid plexus cysts
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(Roberts, Walkinshaw, McCormack, & Ellis, 2000). Finally, Stoll and colleagues reviewed
routine mid-trimester ultrasound screening on 119,099 consecutive pregnancies among lowrisk French women. Only ten of fifty-four (18.5%) Down syndrome fetuses were identified
by an abnormal ultrasound exam. The overall sensitivity for detecting Down syndrome by
ultrasound was 8.1% (10/123). This study only evaluated gross anatomical defects and
specificity was reported as 100% (Stoll, Dott, Alembik, & Roth, 1993). In general, low-risk
population studies reveal that mid-trimester ultrasound screening has decreased sensitivity
for Down syndrome detection.

Patient Perceptions
Regardless of the published detection rate of Down syndrome by ultrasound,
individual perceptions of this number appear to be a factor women consider when deciding
whether or not to undergo an invasive diagnostic test. In conjunction with the perceived
detection rate of Down syndrome, each woman has her own background knowledge of
ultrasound and its sensitivity and purpose. Previous studies vary in their findings making it
difficult to apply general recommendations to our patient population. To our knowledge, no
studies have been performed on a United States population. Previous studies performed
have been primarily on unselected populations of pregnant women examining women’s
attitudes, knowledge, and perception of routine sonograms (Chan et al., 2008; Georgsson
Ohman & Waldenstrom, 2008; Hyde, 1986; Lalor & Devane, 2007). Chan et al. (2008)
explored the background knowledge, expectations and experiences of a Chinese population
of pregnant women regarding routine second trimester ultrasound. The study reported an
overall positive experience from the event but an unsatisfactory knowledge of the
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ultrasound. A Swedish based populations study including women of all risk reported
pregnant women had high expectations of the routine second trimester ultrasound, and their
strongest motivation for the exam was to determine the health of the baby (Georgsson
Ohman & Waldenstrom, 2008). Smith et al. (2004) and Basama, Leonard, & Leighton
(2004) reported a poor patient knowledge of the 20 week anomaly scan performed on
pregnant women in the United Kingdom. Both studies concluded that patients need to better
informed and more educational efforts should be made. In general, studies have shown that
women’s expectations exceed ultrasound capabilities (Chan et al., 2008; Lalor & Devane,
2007; Smith, Titmarsh, & Overton, 2004).
Some reports have shown sufficient understanding and an accurate perception of the
prenatal ultrasound, particularly among populations that are provided written information
about the ultrasound prior to the appointment. Smith et al. (2004) created an education
program and compared two populations’ knowledge about the 20 week anomaly scan. The
found patients who received information prior to the exam answered knowledge-based
questions correctly more often than the control group. Larsen and collaborators included
women of all risk and explored their background knowledge of ultrasound screening in the
second trimester and their overall experience. They asked a series of open and close ended
questions which revealed the following themes. Women have a relatively accurate
understanding of ultrasound examinations supplied by family and friends; however, the
background knowledge can be increased by improved quality and access to information.
Their primary goal is to maintain the health of their baby (Larsen Nguyen, Munk, Svendsen,
& Teisner, 2000). In general, each study population differs slightly in their background
knowledge of prenatal ultrasounds, but there is a common trend of under-estimating
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limitations and over-estimating the capabilities of the ultrasound examination. This is
evident by the multitude of studies reporting a strong reassurance of the health of the baby
from a normal ultrasound and high expectations of the ultrasound to detect any anomalies or
problems.
Different approaches have been taken to determine current perceptions of ultrasound,
both routine exams and anatomy scans. One Swedish study evaluated the perception of
information given before and during routine ultrasound examinations. As part of the
evaluation, women were questioned about the purpose of second trimester ultrasound scan.
Although the information provided prior to ultrasound scanning explicitly stated the main
purposes of the scan to be dating and detection of multiple gestation, 89% of women and
84% of men believed the purpose of the ultrasound was to detect fetal abnormalities. This
reflects that the primary parental concern is the health of the baby (Eurenius, Axelsson,
Gallstedt-Fransson, & Sjoden, 1997).
Basama and colleagues surveyed their patient population including women of all risk
in the UK to assess perception of the purpose of the anatomy scan. The hospital provided
leaflets containing information regarding the 20 week anomaly scan prior to the patient’s
appointment. The group assessed the adequacy of the information provided to the patient.
Ninety-five percent of the women surveyed considered the purpose of the anomaly scan to
be evaluation for structural abnormalities, demonstrating a good understanding. However,
32% believed the purpose of the exam was to detect chromosomal abnormalities, and 32%
of women thought the scan would identify Down syndrome. Women expected the
ultrasound to identify 76%, 76%, 33% and 90% of kidney, limb, heart, and spinal
abnormalities, respectively. Ninety-two percent of women had never heard of soft markers
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for chromosome abnormalities. Although women had a good understanding of the purpose
of the ultrasound, the group concluded that only 8% of women had a realistic assessment of
the capability of the anomaly scan (Basama, Leonard, & Leighton, 2004).
One study in the UK determined patients’ knowledge of the 20-week fetal anatomy
scan and found women were more informed after receiving a patient information sheet
regarding the purpose of ultrasound (Smith et al., 2004). A Canadian study used a
questionnaire to evaluate the understanding of ultrasound in a low-risk population of women
attending a second-trimester anatomy scan. Fifty-five percent of women stated they had not
received previous information about ultrasound scanning prior to the exam, and 46% did not
believe the ultrasound would be used as a screening tool for anomalies. These results
highlight the need for proper evaluation of women’s understanding of sonography as a
screening method for fetal abnormalities in order to meet requirements for informed choice
(Kohut, Dewey, & Love, 2002). The authors of the above mentioned studies highlight the
lack of information provided to patients regarding the ultrasound and discuss the issue of
informed consent.
Even when provided information before and/or after ultrasound examination,
patients have previously established expectations and knowledge of the procedure that are
important to understand in order to provide appropriate counseling and obtain informed
consent.

Significance
Current literature assessing patient perceptions and knowledge of ultrasound is
inconsistent. Results range from appropriate to poor understanding, and conclusions lack
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consistent general recommendations. Study populations and designs are also diverse
making it difficult to apply the information reported to the general population. There are no
perception studies performed on a United States based population. In addition, no studies
concentrate on perceptions of targeted ultrasound and detection rates of Down syndrome in
high risk populations. Many women who test positive on second trimester maternal serum
screening are referred for genetic counseling. Therefore, this information is very important
for providers of genetic counseling to improve patient education and obtain informed
consent. Genetic counselors support patients and help them understand maternal serum
screen results as well as the risks, benefits and limitations of additional screening, such as
ultrasound, and diagnostic tests. Targeted ultrasound is a screening tool widely available
during pregnancy; however, the diagnostic capabilities of ultrasound technology continue to
develop over time. Patient’s knowledge and understanding of available screens continues to
change. Thus, it is important to continuously evaluate current understanding for proper
counseling.

Study Aims
The aim of this study is to determine the perception and knowledge of targeted
ultrasound in women who screen positive for Down syndrome in the first or second
trimester, and to assess the perceived detection rate of Down syndrome by targeted
ultrasound in this population. With this information, genetic counselors and associated
health care professionals may be better equipped to address the screening capabilities of
ultrasound and provide accurate information for informed consent.
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MATERIALS AND METHODS

Study Design
The aim of this study was to determine perception and knowledge of targeted
ultrasound in women who screen positive for Down syndrome in the first or second
trimester, and to assess the perceived detection rate of Down syndrome by targeted
ultrasound in this population. A self-administered questionnaire (Appendix A) was used to
determine participants’ level of understanding of ultrasound and its role in detecting Down
syndrome. Demographic information obtained from the survey included ethnicity,
education, income, and pregnancy history.

Hypothesis
Women who screen positive for Down syndrome do not have an accurate perception
of the detection rate for Down syndrome by targeted ultrasound, as well as the general
capabilities of targeted ultrasound.

Study Approval
The Committee for the Protection of Human Subjects of the University of TexasHouston Health Science Center approved this study on June 16, 2010.

Study Population
The study population consisted of all English and Spanish speaking pregnant women
who were referred to the University of Texas Maternal-Fetal Medicine clinics, which
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includes Memorial Hermann Professional Building, St. Joseph Medical Center, Memorial
Hermann Hospitals – Katy, Memorial City, Sugar Land, Southeast, and Southwest, for
positive first trimester or second trimester screens for Down syndrome. Multiple sites were
included to obtain the greatest number of participants given the time frame for collection.
Patients had to be at least 18 years of age to participate. All women of advanced maternal
age (≥ 35 years of age) were excluded.

Sample Size
The anticipated sample size was 75 women. The sample size was based upon
number of patients that met the above criteria that attended clinic in the previous months as
recorded in the clinical database and the number of months estimated for recruitment. There
was no maximum number at which we stopped recruiting for the study.

Questionnaire
A descriptive questionnaire was created in order to access a sample of women
attending a high risk clinic for a targeted (level II) ultrasound. A review of the literature did
not identify a questionnaire specifically evaluating women’s perceptions of a targeted
ultrasound and its role. Therefore, an instrument was created and revised through several
phases by the committee members to determine whether it was clearly worded and
appropriately structured to gather desired information. A similar review process was
conducted by Kohut, Dewey, and Love (Kohut et al., 2002) when developing a
questionnaire for their prenatal patients aimed to determine women’s perceived value of the
information received by ultrasound and principles of informed consent. Experts within the
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fields relevant to the questionnaire reviewed the screening tool to assess content and
validity.
The questionnaire was constructed on the premise of similar studies in China and
Denmark (Chan et al., 2008; Larsen et al., 2000). There were three main sections: (1)
pregnancy history and sociodemographic characteristics; (2) detection of Down syndrome
by targeted ultrasound; and (3) knowledge of targeted ultrasound.
1. Pregnancy history and sociodemographic questions: There were nine questions
regarding the patient’s previous and current pregnancy history as well as common
demographic questions (average household income, education level, and
race/ethnicity).
2. Detection of Down syndrome by targeted ultrasound questions: There were four
questions in this section, used to determine the perception of the detection rate of
Down syndrome by ultrasound.
3. Knowledge of targeted ultrasound questions: There were two questions used to
determine if a patient knew what a targeted ultrasound was and if they had
previously had one performed. The final question had a subset of fifteen items. The
goal of this question was to determine if the participant believed it is possible for a
targeted ultrasound to identify any one of the listed items.
Every question was multiple choice. At the midpoint of collection, a modification was
made to the questionnaire to include “Don’t know” as an answer choice for two of the
questions pertaining to the detection rate of Down syndrome by targeted ultrasound.
This was done due to the high non-response rate for the two questions.
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Data Collection
Women meeting study criteria were identified prior to their genetic counseling
appointment. An information sheet describing the study was given to eligible patients
(Appendix B). Women who chose to participate completed the questionnaire and returned
them to the genetic counselor or front desk staff. Data collection began on June 21, 2010
and ended on February 4, 2011.

Statistical Analysis
Data collected from the questionnaires was entered into a Microsoft Access database.
The database was analyzed using statistical analysis software program, STATA (v.10,
College Station, TX). For our primary analysis, we performed a descriptive analysis to
evaluate the perception/knowledge of the detection of Down syndrome by targeted
ultrasound. The number and proportion of women selecting each answer option in questions
9-11 were tabulated, along with the median and most common response for each question. A
similar descriptive analysis of each defect in question 12, provided information on
perception/knowledge of detection of specific congenital defects. A secondary analysis of
the data was performed after stratifying by various demographic factors (race/ethnicity,
household income), pregnancy history and history of birth defects. For the stratified analysis
we used contingency tests (Fisher’s exact test, Chi-squared test) to compare the proportion
of women that selected each answer option. External validity for demographic information
obtained by the questionnaire was confirmed by checking with previous studies performed
on the same clinic population. Results with a p-value of less than 0.05 were considered
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statistically significant. The null hypothesis used for all statistical tests was that there was
no difference between groups.

30

RESULTS

Between June 21, 2010 and February 4, 2011, 77 women chose to participate in the study.
Of the 77 participants, the majority were recruited from UTPB (32%) and St. Joseph
Medical Center (26%). The other Memorial Hermann collection sites, Memorial City, Katy,
Southwest, Southeast, and Sugar Land had 8%, 13%, 4%, 9%, and 8% of collected surveys
respectively. Nearly 94% of the surveys collected were in English.

Demographics
The racial-ethnic background of the participants was divided among five categories:
Caucasian, African American, Hispanic, Asian, and other. Two individuals chose “other”
and identified themselves as Asian Indian and Middle Eastern. These individuals were
grouped into the Asian category for statistical analysis. Table 1 shows the racial-ethnic
breakdowns for each group.
The highest level of education completed was categorized by some high school, high
school, some college, bachelor degree, and post-graduate or professional degree. To
increase the power in the analysis, the education levels were re-grouped from five groups
into two groups: less than a college degree and a college degree or higher (Table 1). The
combined household income categories were also tabulated (Table 1).
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Table 1: Demographic Background of Participants
Demographics

Counts (n)

Percent (%)

Race/Ethnicity*
Caucasian
African American
Hispanic
Asian
Total

29
16
20
9
74

39.19
21.62
27.03
12.16
100

Less than College Degree
College Degree or Higher
Total

51
22
73

69.86
30.14
100

14
13
17
13
5
8
70

20
18.57
24.29
18.57
7.14
11.43
100

Education**

Income***
< $10,000
$10,000-$25,000
$25,000-$50,000
$50,000-$75,000
$75,000-$100,000
> $100,000
Total
* 3 individuals did not answer this question
** 4 individuals did not answer this question
*** 7 individuals did not answer this question

Correlations between race/ethnicity, education and income were evaluated and
significant differences were found between the results from race/ethnicity and education
(p<0.001), race/ethnicity and income (p=0.001), and education and income (p<0.001). In
general, individuals with more education were more likely to have a higher gross annual
income. Asians and Caucasians were more likely to have completed higher education than
African Americans and Hispanics (Table 2). More specifically, there was a significant
difference between the education levels of Hispanics and Caucasians (p=0.004) and
Hispanics and Asians (p<0.001).
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Table 2: Distribution of Total Household Income by Racial-Ethnic Background
Racial-Ethnic Background
Income
Less than $10,000
$10,000-$25,000
$25,000-$50,000
$50,000-$75,000
$75,000-$100,000
Greater than $100,000
Total

African
American
5
3
3
2
1
0
14

Hispanic

Asian

5
5
6
3
0
0
19

Caucasian
1
0
2
2
1
3
9

3
5
6
6
3
5
28

Total
14
13
17
13
5
8
70

Finally, there was a significant difference between the racial distribution among the
collection sites (p=0.009). St. Joseph Medical Center was more strongly represented by
Hispanics and UTPB and Memorial Hermann Katy had a higher percentage of Caucasians.
The other clinics had a slightly more diverse population with regard to race/ethnicity.

Pregnancy History
Participants reported total number of pregnancies, number of living children, and
number of ultrasounds during current pregnancy (Table 3).
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Table 3: Pregnancy History of Participants
Pregnancy History
Number

n (%)

Total Pregnancies
1
2
3
4
5 or more

30 (38.96)
16 (20.78)
16 (20.78)
10 (12.99)
5 (6.49)

0
1
2
3
4

34 (44.16)
20 (25.97)
15 (19.48)
7 (9.09)
1 (1.3)

Living Children

Ultrasound During Pregnancy*
No 7 (9.09)
Yes 68 (88.31)
Number of Ultrasounds**
1 31 (40.26)
2 20 (25.97)
3 8 (10.39)
4 6 (7.79)
5 0 (0)
6 1 (1.3)
* 2 individuals did not answer this question
** 11 individuals did not answer this question

Information regarding women’s experience with a genetic disorder or birth defect
was obtained. Women were asked if they had a child with a genetic condition and/or birth
defect, and 96.1% (74/77) answered no. Of the three women who reported yes, the
conditions or birth defects recorded were “Thalassemia B”, “tumor on head”, and “sacral
dimple hemangioma.” Women were also asked if they knew anyone with a genetic condition
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or birth defect. Almost 29% (22/77) answered yes. Figur
Figuree 1 and Table 4 show the
breakdown of answers for this question.

Figure 1: Do You Know Anyone with a Genetic Disorder or Birth Defect?
6%

1%

No
29%

Yes
Don't Know
Missing
64%

Table 4: If yes, what condition/birth defect did they have?*
Genetic Condition or Birth Defect

Frequency

Spina bifida
Down syndrome

1
11

Cleft lip and palate

1

Autism

1

Tuberous sclerosis

1

Trach-ear
ear deformity

1

Hand/leg deformity

1

Trisomy 13

1

Infertility

1

Unknown

1

*Data not mutually exclusive and 5 women did not answer
35

Knowledge of Targeted Ultrasound
Several questions were designed to evaluate the participants’ knowledge of targeted
ultrasound. A number of the women omitted responses to some of the questionnaire items,
so the number of respondents varied per question. Question two (Q2) categorized women
into groups: women who heard of a targeted ultrasound, women who have not heard of a
targeted ultrasound, and women who did not know if they had heard of a targeted
ultrasound. Fifty-five (73%) women had heard of a targeted ultrasound (Figure 2a). Of the
women who reported hearing of a targeted ultrasound, question 2a (Q2a) asked what was the
source of their information (Figure 2b). Question 3 (Q3) asked how many targeted
ultrasounds have you had prior to today in any pregnancy (current or past). Most women
reported never having a targeted ultrasound (63/77) regardless of whether they had heard of
one or not. Three women who reported never hearing of a targeted ultrasound recorded
having 1, 3, and 4 targeted ultrasounds. Figure 3 shows the overall number of targeted
ultrasounds reported by participants.
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Figure 2a: Q2: Have you heard of a targeted ultrasound?
Don't Know Yes
n=75

No

6%

21%

73%

Figure 2b: Q2a: If yes, where did you hear about the targeted ultrasound?*

Percentage of Women (n=22)

45%
40%
35%
30%
25%
20%
15%
10%
5%
0%

Family

Friend

Internet

Doctor

Brochure

Other

Information Source
*Data not mutually exclusive
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Figure 3: Q3: How many targeted ultrasound have you had prior to today in any
pregnancy (current or past)?

Number of women (N=77)

70
60
50
40
30
20
10
0

0

1

2

3

4

Missing

Number of targeted ultrasounds

Question number 12 asked: With the understanding that ultrasound may be limited
by gestational age and position of baby, in most cases, it is possible for a targeted ultrasound
to detect any of the following in the baby: cleft lip, function of baby’s brain, due date,
structure of heart, spina bifida, mental retardation, number of babies (single v. twin), health
of baby,
aby, chromosome problem(s), facial features of Down syndrome, kidney structure, signs
of Down syndrome, gender of baby, autism, and structure of brain. Choices for the answer
included “yes,” “no,” and “don’t know.” Answers to each question were categorized
categorize by
correctness. For example, it is possible for a targeted ultrasound to detect cleft lip, so the
correct answer is yes. Conversely, it is not possible for a targeted ultrasound to detect
mental retardation, so the correct answer is no. In this case, individuals that chose “yes” as
their answer for detection of cleft lip and individuals that answered “no” for detection of
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mental retardation were labeled as correct. This categorization was done for each question.
Figure 4 shows the percentage of each question that was answered correctly, incorrectly,
don’t know, and unanswered. When comparing answers about ultrasound findings that refer
to structural features (e.g. cleft lip, due date, and gender) to those that refer to functional or
biological features
es (e.g. health of baby, mental retardation, and autism), women answered
the structural questions correctly more often. For each ultrasound finding, 9 to 13 (11-17%)
(11
women did not answer the question.
Figure 4: Is it Possible for a Targeted Ultrasound to Detect Each of the Following in
the Baby?
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Percent Answered

70%
60%
50%
40%
30%
20%
10%
0%

No Answer
Don't Know
Incorrect

Ultrasound Finding

Correct
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Fisher exact tests were performed to determine if the answers for ultrasound
knowledge questions differed by race/ethnicity (Table 5). Missing data was not included in
the analysis in order to avoid skewed results. Responses to ultrasound knowledge questions
were significantly different by race/ethnicity for the following: due date, number of fetuses,
chromosome problem(s), and kidney structure with p values <0.05.

Table 5: Fisher Exact Tests for Significance between Ultrasound Knowledge and
Race/Ethnicity
Ultrasound Finding

p=value*

Cleft lip

0.140

Function of baby's brain

0.182

Due date

0.001

Structure of heart

0.199

Spina bifida

0.589

Mental retardation

0.120

Number of babies

0.022

Health of baby

0.543

Chromosome problem(s)

0.015

Facial features of Down syndrome

0.278

Kidney structure

0.009

Signs of Down syndrome

0.113

Gender of baby

0.057

Autism

0.355

Structure of brain

0.141

*p<0.05 is significant

Caucasians correctly answered ultrasound’s ability to determine due date more frequently
than African Americans, Hispanics, and Asians (Figure 5). Caucasians chose the correct
answer more frequently than Hispanics when responding to ultrasound’s ability to detect
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number of fetuses (Figure 6). When answering whether ultrasound is able to detect
chromosome problem(s), the majority of individuals, regardless of race/ethnicity,
race/ethnicity did not
know the correct answer. However, Hispanics were sign
significantly
ificantly different than the other
racial groups in that none answered the question correctly and the majority chose “don’t
know” as their answer (Figure 7). Lastly, Caucasians were more likely to choose the correct
answer for ultrasound’s ability to dete
determine
rmine kidney structure compared to Hispanics and
Asians (Figure 8).

Figure 5: Answers to Targeted Ultrasound’s Ability to Determine Due Date by
Race/Ethnicity
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(a) Significant difference between African American and Caucasian (p<0.001)
(b) Significant difference between Hispanic and Caucasian (p=0.005)
(c) Significant difference between Asian and Caucasian (p=0.008)
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Figure 6: Answers to Targeted Ultrasound’s Ability to Identify Number of Fetuses by

Percent Answered
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Figure 7: Answers to Targeted Ultrasound’s Ability to Detect Chromosome Problem(s)
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by Race/Ethnicity
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(a) Significant difference between Hispanic and Caucasian (p=0.008)
(b) Significant difference between African American and Hispanic (p=0.013)
(p=0.0
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Figure 8: Answers to Targeted Ultrasound’s Ability to Determine Kidney Structure by
Race/Ethnicity
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(a) Significant difference between Hispanic and Caucasian (p=0.002)
(b) Significant difference between Asian and Caucasian (p=0.037)

Similarly, the answers fo
forr each ultrasound knowledge question were compared to
education level of participants. Table 6 includes all Fisher exact test p values. Responses
were significant for the following: cleft lip, function of baby’s brain, and structure of brain.
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Table 6: Fisher Exact Tests for Significance between Ultrasound Knowledge and
Education
Ultrasound Finding
Cleft lip
Function of baby's brain
Due date
Structure of heart
Spina bifida
Mental retardation
Number of babies
Health of baby
Chromosome problem(s)
Facial features of Down syndrome
Kidney structure
Signs of Down syndrome
Gender of baby
Autism
Structure of brain
*p<0.05 is significant

p=value*
0.046
0.004
0.697
0.461
0.739
0.063
0.112
0.698
0.448
0.144
0.336
0.088
0.370
0.644
0.024

A few general trends were observed. First, individuals in the higher education category were
more likely to choose the correct answer. Second, individuals with less education were
more likely to choose “don’t know.” Third, whether correct or incorrect, individuals that
had a college degree or higher were more likely to choose an answer as opposed to “don’t
know” (Figures 9-11).
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Figure 9: Answers to Targeted Ultrasound’s Ability to Detect Cleft Lip by Education
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Figure 10: Answers to Targeted Ultrasound’s Ability to Determine Function of Baby’s
Brain by Education
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Figure 11: Answers to Targeted Ultrasound’s Ability to Detect Structure of Brain by
Education
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To determine the more influential variable for participants’ answers, responses were
stratified by education and then tested for significance by race/ethnicity.. Results were not
significant for comparisons between race/ethnicity within the higher education category.
Ultrasound findings including due date, chromosome problem(s), and kidn
kidney
ey structure were
significant between certain racial groups within the lower education category. Specifically,
among individuals with less than a college degree, significant differences were seen between
answers given by African Americans and Caucasians, as well as Hispanics and Caucasians.
In both circumstances, Caucasians were more likely to answer correctly. Among
participants with less than a college degree answering the ultrasound knowledge question
regarding chromosome problem(s), Caucasians were m
more
ore likely to answer correctly and
Hispanic individuals primarily answered “don’t know.” Similarly, a significant difference
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between responses from African Americans and Hispanics was due to the vast majority of
Hispanics answering “don’t know.” The same trend was seen between Hispanic and
Caucasian respondents for detection of kidney structure. Although a consistent trend was
not observed, it appears race/ethnicity is an influential component among individuals that
are less educated. Conversely, data was stratified by race/ethnicity and tested for
significance by education. No trends were observed. In summary, it appears race/ethnicity
is not confounding education, and education is only confounding race/ethnicity when
individuals are less educated.
Finally, participants’ responses were compared to whether or not women had heard
of a targeted ultrasound. Answers choices for the question, “have you heard of a targeted
ultrasound?” were “yes,” “no,” and “don’t know.” Responses were grouped into two
categories: yes and no. Individuals that chose no or don’t know as their response were
grouped together for analysis in the no category. This was done to compare women that
knew they had heard of a targeted ultrasound to others. Results are shown in Table 7.
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Table 7: Chi Squared Tests for Significance between Ultrasound Knowledge and
Women Who Have Heard of a Targeted Ultrasound
Ultrasound Finding

p=value*

Cleft lip

0.019

Function of brain

0.110

Due date

0.756

Structure of heart

0.113

Spina bifida

0.086

Mental retardation

0.035

Number of babies

0.800

Health of baby

0.065

Chromosome problem(s)

0.023

Facial features of Down syndrome

0.073

Kidney structure

0.147

Signs of Down syndrome

0.075

Gender of baby

0.467

Autism

0.380

Structure of brain

0.503

*p<0.05 is significant

Answers to ultrasound knowledge questions regarding cleft lip, mental retardation, and
chromosome problem(s) were significantly different. For answers regarding ultrasound’s
ability to detect cleft lip, women who had heard of a targeted ultrasound were more likely to
answer correctly (Figure 12). A larger percentage of women who had heard of a targeted
ultrasound answered the question regarding ultrasound’s ability to detect mental retardation
correctly compared to those who had not heard of targeted ultrasound.
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Figure 12: Answers to Targeted Ultrasound’s Ability to Detect Cleft Lip by Women
Who Have Heard of a Targeted Ultrasound
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Although women who had previously heard of a targeted ultrasound answered the question
correctly more frequently, this ggroup
roup also had a higher percentage of respondents choosing
the incorrect answer compared to the other group. Women who had heard of a targeted
ultrasound were more likely to choose an answer, whether right or wrong, as opposed to
“don’t know”, which is a trend
rend similar to that noted earlier among more educated
participants (Figure 13).
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Figure 13: Answers to Targeted Ultrasound’s Ability to Detect Mental Retardation by

Percent Answered

Women Who Have Heard of a Targeted Ultrasound
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In contrast to the above results, iindividuals
ndividuals who had heard of a targeted ultrasound were
more likely to answer incorrectly for ultrasound’s ability to detect chromosome problem(s)
(Figure 14).
Figure 14: Answers to Targeted Ultrasound’s Ability to Detect Chromosome
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Of note, comparisons were made between responses from ultrasound knowledge questions
and women who reported hearing of the targeted ultrasound from their doctor versus
someone other than their doctor. There were no differences between the source of
information and the respondents’ answers.

Perception of Detection Rate of Down Syndrome by Targeted Ultrasound
Three of the questions on the questionnaire were designed to assess the participants’
perception of the detection rate of Down syndrome by targeted ultrasound, referred to in this
section as perception questions. Again, missing data was not used in calculations. Before
determining perception, women were asked if they had heard of Down syndrome. Two
women out of 77 had not heard of Down syndrome and 2 women answered “don’t know.”
The remaining 73 women had heard of Down syndrome. The first question directed toward
evaluating the participant’s perspective stated: “A targeted ultrasound will be able to tell you
if your baby has Down syndrome” (Q9). The answer choices included: never, rarely,
sometimes, most of the time, always, and don’t know. The second question (Q10) asked,
“What percent of babies with Down syndrome will have an abnormal finding on a targeted
ultrasound?” Finally, question three asked (Q11): “Does a “normal” targeted ultrasound
result guarantee that the baby will be born without Down syndrome?” For the remainder of
the results, the preceding three questions are referred to as Q9, Q10, and Q11. The results of
these questions are found in Figures 15-17.
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Figure 15: Q9: A targeted ultrasound will be able to tell you if your baby has Down
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Figure 16: Q10: What percent of babies with Down syndrome will have an abnormal
finding on a targeted ultrasound?
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Figure 17: Q11: Does a “normal” targeted ultrasound result guarantee that the baby
will be born without Down syndrome?
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Answers to the three perception questions were compared to race/ethnicity for
significance. Contingency tes
tests between race/ethnicity and answers from women who had
or had not heard of Down syndrome, Q9, and Q10 were not significant (p>0.05). However,
Caucasians were more likely to answer Q11 correctly, answered “No,” compared to
Hispanics and African Americans (Figure 18).
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Figure 18: Answers to Q11: “Does a “normal” targeted ultrasound result guarantee

Percent Answered

that the baby will be born without Down syndrome?” by Race/Ethnicity
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(a) Significant difference between African American and Caucasian (p=0.030)
(b) Significant difference between Hispanic and Caucasian (p<0.001)

Contingency tests were also performed between education and perception questions.
There were no significant differences between the answers from women who had or had not
heard of Down syndrome, Q9, Q10, and Q11 (p>0.05).
Finally, the same questions were compared with whether or not participants had
heard of a targeted ultrasound. As noted previously, participants that chose “no” or “don’t
know” to “have you heard of a targeted ultrasound” were combin
combined
ed into a single category,
no. Results were not significant (p>0.05) for the following: “Have you heard of Down
syndrome?” Q9, Q10, and Q11. When comparing women who had heard of the targeted
ultrasound from their doctor versus someone other than their ddoctor,
octor, women were more
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likely to answer Q11 correctly if they reported hearing of the targeted ultrasound from their
doctor (p=0.024).
When comparing answers to the question “Have you heard of Down syndrome?” to
answers for Q9, Q10 and Q11, no significant differences were found. Answers between Q9
and Q10 were significantly different (p<0.001). While, most women chose “don’t know”
for both questions, those who thought ultrasound would be able to detect Down syndrome at
least some of the time (Q9), answered correspondingly to Q10. For example and individual
who answered “most of the time” to Q9 was more likely to answer “51%-75%” to Q10.
Responses between Q10 and Q11 were also significantly different (p=0.003), although the
majority of responses were “don’t know” for both questions.
Similarly to the analysis performed on ultrasound knowledge data, in an attempt to
identify factors that most influenced participants’ answers, responses were stratified by
education and race/ethnicity. No overall trends were observed, but results from Q11
stratified by education and testing for differences between race/ethnicity was significant
between Hispanics and Caucasians. Among individuals with less than a college degree,
Hispanics were more likely to answer “don’t know” and Caucasians were more likely to
answer correctly.

Overall Accuracy
Results of perception questions were compared for accuracy. Of note, only 14.3% of
individuals got 2 of the 3 questions correct; no one answered all three perception questions
correctly. Ultrasound knowledge questions regarding detection of mental retardation and
chromosome problem(s) were also included because of their relationship with Down
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syndrome. With 5 questions pertaining to detection of Down syndrome by targeted
ultrasound, 3.9% of participants got 4 out of 5 answers correct.
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DISCUSSION

The purpose of this study was to determine the perception and knowledge of targeted
ultrasound in women who screen positive for Down syndrome in the first or second
trimester, and to assess the perceived detection rate of Down syndrome by targeted
ultrasound in this population. It was hypothesized that women would not have an accurate
perception and knowledge of the targeted ultrasound and its role in detecting Down
syndrome. A total of 77 women participated in the study.
Previous studies have examined patient expectations and knowledge of routine
ultrasound scans in the first and second trimester. In the past, surveys have been performed
in Denmark (Larsen et al., 2000), the United Kingdom (Basama et al., 2004; Smith et al.,
2004), Ireland (Lalor & Devane, 2007), Sweden (Eurenius et al., 1997), China (Chan et al.,
2008), and Canada (Kohut et al., 2002). Due to cultural and institutional differences, the
patient perceptions identified in their studies may not be applicable to the patient population
in the United States, particularly in our clinics. In addition, there are no studies to date that
examine the patients’ knowledge of the targeted ultrasound and its ability to detect certain
anomalies. Therefore, this cross-sectional, descriptive study is the first to compare the
perceptions of high risk patients regarding the targeted ultrasound and its role in detecting
specific ultrasound anomalies and Down syndrome.

Demographics
Demographic data obtained from the questionnaire was comparable to other studies
performed in the same clinics (Czerwinski et al., 2010; Hoskovec et al., 2008). Overall,
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significant differences among demographic variables showed typical trends. Individuals
with a higher education were more likely to have a higher combined household income.
Individuals of Caucasian or Asian ethnicity were more likely to earn a higher education.
There is likely a positive feedback effect among families with a higher income capable of
providing higher education as well as the fact that individuals with more education earn a
higher salary.
Education and income are both indicators of socioeconomic status. For the purposes
of further analysis, education was used as a comparison because it is a better measure of
intrinsic ability to understand and synthesize information. Race/ethnicity was also used in
order to tailor counseling provided to patients at different clinics with varied racial-ethnic
populations.

Targeted Ultrasound Knowledge
In general, previous studies have shown that patient knowledge about ultrasound is
unsatisfactory. This is supported by our study. On average, women answered ultrasound
questions correctly 36% of the time and did not know the answer or did not answer the
question 54% of the time. This is comparable with Chan et al. (2008) reporting 47% of
patients could answer 13 of 19 questions regarding capabilities of a routine ultrasound
correctly. Chan et al. (2008) study population included women attending either first or
second trimester routine ultrasound exams. Their higher percentage of correct answers may
reflect more exposure to the general expectations from a routine ultrasound compared to
those associated with the targeted ultrasound our population was referred for. More than
50% of the participants in our study correctly answered detection of routine findings such as
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due date, structure of heart, number of fetuses, and gender more frequently than other
ultrasound knowledge questions. Previous studies are consistent with this finding keeping in
mind that the previous studies were designed to assess perception and knowledge of routine
ultrasound exams. Chan and colleagues determined 92% of their participants knew the
purpose of the ultrasound was to identify fetal gender and 95% reported the use for
visualizing fetal heart movement. Lalor et al. (2007) and Eurenius et al. (1997) both
reported a good patient knowledge of ultrasound’s ability to diagnose multiple pregnancies.
In addition, the latter group reported patients having high expectations for confirming
estimated date of confinement (Eurenius et al., 1997). Subsequently, participants in our
study incorrectly answered ultrasound questions regarding detection of facial features of
Down syndrome and the health of the baby. It has been reported that parents’ main concern
and motivation for ultrasound examination is to monitor the health of the baby (Eurenius et
al., 1997; Lalor & Devane, 2007). Parents likely have reassurance based on the result of a
“normal” ultrasound, although the actual health of the baby cannot be determined. The high
percentage of incorrect answers for detection of facial features of Down syndrome is likely
due to the fact that it refers to a structural aspect of the fetus. Although ultrasound is used to
evaluate the structural anatomy of the fetus, including some specific facial structures such as
nose and mouth (e.g. cleft lip), subtle features such as epicanthal folds and downslanting
palpebral fissures are unable to be detected. This may be attributed to society’s high
expectations of modern medical technology, particularly with the more common use of 3-D
and 4-D ultrasound.
Results revealed a difference between ultrasound knowledge and ethnicity. In
general, Caucasians answered questions correctly more frequently than other groups. There
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are several factors that may influence this affect. Social groups exist between individuals
within racial groups that may expose one group to more information than another. In
addition to access to information provided by social groups, individuals may have access to
different resources such as the internet. Although the questionnaire was available in both
English and Spanish, the vast majority (94%) were completed in English. It is possible that
women who speak English as their second language received an English questionnaire,
when they would have been more comfortable reading a Spanish version. This group of
women is likely very small, but language barriers may have been present in this type of
scenario. Finally, it has been well documented that Hispanics and African Americans are
often late to receive prenatal care (Frisbie, Echevarria, & Hummer, 2001). It is possible that
previous experiences either aid or hinder the ability to answer questions correctly.
There were three main trends observed when comparing answers to ultrasound
knowledge and education level. One, individuals with higher education were more likely to
answer correctly. Two, individuals with higher education were more likely to choose an
answer, whether correct or incorrect. Finally, individuals with less education were more
likely to choose “don’t know” as an answer. A similar result was shown by Chan et al.
(2008). They reported 92% of individuals with non-tertiary level of education had poor
ultrasound knowledge compared to only 4% of individuals with a tertiary level. Of their
population with a tertiary level of education, the majority of individuals were recorded as
having a good knowledge of ultrasound. The findings were not surprising. Participants that
had more education are probably more confident when choosing an answer because of
previous experiences. It is reasonable to assume individuals with a college education or
higher have had more exposure to questionnaires, exams, and making educated guesses.
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There is also a higher chance that they can synthesize information and better understand the
questions. On the other hand, participants reporting less than a college degree may feel that
choosing “don’t know” is a safer choice.
Finally, individuals who had previously heard of a targeted ultrasound answered the
questions regarding ultrasound knowledge correctly more often. Also, individuals who
reported previously hearing of a targeted ultrasound were more likely to have also had an
accompanied discussion about the ultrasound or read additional information. Interestingly,
participants who had heard of the targeted ultrasound were more likely to answer the
question about ultrasound’s ability to detect chromosome problems incorrectly. This may be
due to a referral bias for these women. Under the assumption that they heard of the targeted
ultrasound after learning of their positive screening result, it is possible they misinterpreted
that the targeted ultrasound was recommended to determine if the baby had Down syndrome
as opposed to evaluating the fetus for anomalies associated with an increased risk for Down
syndrome.

Perception of the Detection Rate of Down Syndrome by Targeted Ultrasound
To date, no studies focusing on patient perception of the detection rate of Down
syndrome by targeted ultrasound have been published. One study asked women if
ultrasound could diagnose chromosomal abnormalities (e.g. Down syndrome). Forty-three
percent of respondents answered correctly, 30% answered incorrectly, and 29% did not
know the answer (Chan et al., 2008). Similarly, one in three women from Lalor and
Devane’s study population thought the ultrasound exam would detect Down syndrome and
other chromosomal abnormalities (Lalor & Devane, 2007). In contrast to the previous
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studies, we asked participants to answer how often they thought Down syndrome was
diagnosed by ultrasound (Q9). Only 4% of our population answered the question correctly,
choosing “never”, while 45% answered incorrectly. The next question (Q10) was used to
expose the difference between a diagnosis of Down syndrome and the detection rate by
ultrasound. This question highlights the limitation of ultrasound and its purpose of
identifying abnormal structures, as opposed to diagnosing underlying etiologies. Similar to
the answers from Q9, only 12% of participants answered Q10 correctly, and 19% answered
the question incorrectly. The remaining individuals either answered “don’t know” or did not
answer the question. It is clear that our patient population did not have good background
knowledge of ultrasound as it pertains to detecting Down syndrome. In contrast to the prior
to questions, participants had a higher accuracy when responding to the third perception
question (Q11), although there was still a large percentage of individuals that chose “don’t
know.” It appears women better understand that ultrasound cannot offer any guarantees and
that problems may still exist. This was also seen in a study by Smith et al. (2004) when
patients were asked “If the scan is normal, the baby might still have a problem.” Seventyeight percent of their participants correctly understood this statement to be true. Our
population had a more difficult time answering questions that were more knowledge-based
requiring a basic understanding of medical terminology.
Overall, we were not able to determine if women over or under-estimated the
capabilities of targeted ultrasound when detecting Down syndrome, because there was a
wide range of answers to the questions and an even larger percentage of individuals
reporting that they did not know the answer. It seems that our patient population lacks
background knowledge to form an initial perception. Answers to Q9 indicate an over-
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estimation of ultrasound’s ability as few women knew that ultrasound would never diagnose
Down syndrome. The answers to this question may represent an underlying comprehension
issue. Women may not understand the difference between diagnosing a chromosome
problem versus identifying abnormal findings on ultrasound that suggest an underlying
chromosome problem.
To determine the level of background knowledge of targeted ultrasound we assessed
how often combinations of questions were answered correctly by a single participant. By
and large, our study population’s ultrasound knowledge was limited. Only 14% of our
participants could answer 2 out of the 3 perception questions (Q9, Q10, Q11) correctly.
When we added ultrasound knowledge questions related to Down syndrome, including the
detection of mental retardation and chromosome problems by ultrasound, only 4% of our
study population answered 4 out of 5 questions correctly. Although it is unrealistic to
assume individuals in the general population would accurately answer all of the questions, it
is surprising to see that such a low percentage answered a combination of the questions
correctly. In general, the results from our study display a limited amount of background
knowledge in our referral population.

Additional Factors to Consider
It is important to explore the effect of stress and/or anxiety as it relates to the ability
to complete questionnaires in a clinical setting such as ours. Studies show women
experience anxiety after receiving a positive serum screen result for Down syndrome
(Marteau et al., 1992; Weinans et al., 2000). In addition, acute stress causes several adverse
affects such as: impaired ability to retrieve memories, limited attentional resources
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(increased selective attention), and sub-optimal decision making (Buchanan, Tranel, &
Adolphs, 2006; Chajut & Algom, 2003; Keinan, 1987). While filling out the questionnaire
prior to genetic counseling, it is possible that one or multiple of these adverse affects played
a role in the ability of the participant to accurately complete the questionnaire. These factors
are more likely to play a role in the results of this study compared to those that were
previously mentioned, such as Chan et al. (2008), because the other patient populations
completed the questionnaires or studies while attending routine ultrasound exams and were
not referred due to a high risk indication. It is important to keep this in mind while
counseling patients in order to provide detailed, important information in a simple,
understandable manner. This is crucial for patient autonomy and informed decision making.
Larsen and colleagues make an argument that information provided to pregnant
women prior to ultrasound examinations is insufficient (Larsen et al., 2000). Previously, it
was suggested that women undergo ultrasound because it has been integrated as a routine
part of prenatal care as opposed to making an informed decision (Mitchell, 2004). Our study
reinforces that patient knowledge of targeted ultrasound and its role in detecting Down
syndrome is poor, which raises the question: how “informed” of a decision are our patients
making? As ultrasound’s role in prenatal care continues to evolve, it is of utmost importance
that women are informed of the limitations, as well as the purpose of the ultrasound, to
avoid false expectations and equip women with information that may prepare them for a
problem identified by ultrasound.
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Limitations and Future Studies
There are limitations in this study that are related to a self-administered
questionnaire and small sample size. There was no reliability or internal validity tests
performed on the questionnaire. It was created by the committee and piloted among genetic
counselors to test understanding and clarity. There was missing data that is a common
problem seen in self-administered questionnaires. The small sample size of our study
prevented statistical support to confirm trends observed in the data. Questions evaluating
patient knowledge, designed to aid in appropriate counseling, may misrepresent a patient’s
actual understanding. The participant may have the correct information regarding the
detection rate of Down syndrome or other ultrasound findings by ultrasound but be unable to
recall the answer at the time of the appointment. It is also possible that friends or family, if
present when the respondent was filling out the questionnaire, may have influenced their
answers on the questionnaire.
As medical technology and diagnostic capabilities of ultrasound continue to evolve
over time, patient perceptions will also change. It is important to continuously evaluate
patient knowledge in efforts to improve counseling and acknowledge patients’ right to
informed consent. Future studies of interest include a before and after questionnaire to
evaluate the usefulness of the genetic counseling session as it pertains to patients’
knowledge of targeted ultrasound. An evaluation of patients’ decisions regarding invasive
testing in light of their knowledge of targeted ultrasound would be helpful to assess if their
perception has an effect on their decision. Finally, a review of the available sources of
education about targeted ultrasound and a study to examine if one education technique such
as written information, counseling session, or internet is more effective than others.
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Conclusion
Prior to genetic counseling, women do not have an accurate knowledge of the
targeted ultrasound and its role in detecting Down syndrome. There is a general lack of
understanding that prevents individuals from having the ability to form a perception. It is
imperative to assess perception and discuss the purpose and limitations of the targeted
ultrasound with patients prior to ultrasound examinations. Providing appropriate
information to our patients will equip them with the tools to make an informed decision
about the ultrasound and any additional diagnostic or screening tests.
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APPENDIX A
University of Texas-Medical School at Houston
Knowledge and Perception Down syndrome and Targeted Ultrasound
Instructions: Please read each question and mark your answer. Try to answer every
question as best you can. Thank you.

Targeted Ultrasound Information:
Targeted ultrasound is a special ultrasound during the second trimester of pregnancy that looks at the
baby’s organs. This ultrasound is also referred to as an anatomy scan, level II ultrasound, or genetic
ultrasound.

1. Have you had an ultrasound of any kind during this pregnancy?
(A) Yes
(B) No
(C) Don’t know
a. If yes, how many? _________________________________
2. Have you heard of a targeted ultrasound?
(A) Yes
(B) No
(C) Don’t know
a. If yes, where did you hear about the targeted ultrasound?
(A) Family
(B) Friend
(C) Internet
(D) Doctor
(E) Brochure
(F) Other: ______________
3. How many targeted ultrasounds have you had prior to today in any pregnancy
(current or past)?
(A) 0
(B) 1
(C) 2
(D) 3
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(E) 4
(F) 5 or more
4. How many total pregnancies have you had (including the current one)?
(A) 1
(B) 2
(C) 3
(D) 4
(E) 5 or more
5. How many living children do you have?
(A) 0
(B) 1
(C) 2
(D) 3
(E) 4
(F) 5 or more
6. Have you had a child with a genetic condition or birth defect?
(A) Yes
(B) No
a. If yes, what was the name of the genetic condition or birth defect?
_________
7. Do you know anyone (friends/relatives/coworkers) who has a child or a personal
history of a genetic disorder or birth defect?
(A) Yes
(B) No
(C) Don’t know
a. If yes, what condition or birth defect did they have? ________________
8. Have you heard of Down syndrome?
(A) Yes
(B) No
(C) Don’t know
9. A targeted ultrasound will be able to tell you if your baby has Down syndrome.
(A) Never
(B) Rarely
(C) Sometimes
(D) Most of the time
(E) Always
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10. What percent of babies with Down syndrome will have an abnormal finding on a
targeted ultrasound?
(A) 76-100% of babies
(B) 51-75% of babies
(C) 26-50% of babies
(D) 5-25% of babies
(E) <5% of babies
11. Does a “normal” targeted ultrasound result guarantee that the baby will be born
without Down syndrome?
(A) Yes
(B) No
(C) Don’t know
12. With the understanding that ultrasound may be limited by gestational age and
position of baby, in most cases, it is possible for a targeted ultrasound to detect
any of the following in the baby.
Circle one answer for each question.
a. Cleft lip

YES

NO

DON’T KNOW

b. Function of baby’s brain

YES

NO

DON’T KNOW

c. Due date

YES

NO

DON’T KNOW

d. Structure of heart

YES

NO

DON’T KNOW

e. Spina bifida

YES

NO

DON’T KNOW

f. Mental retardation

YES

NO

DON’T KNOW

g. Number of babies (single v. twin)

YES

NO

DON’T KNOW

h. Health of baby

YES

NO

DON’T KNOW

i. Chromosome problem(s)

YES

NO

DON’T KNOW

j. Facial features of Down syndrome

YES

NO

DON’T KNOW

k. Kidney structure

YES

NO

DON’T KNOW

l. Signs of Down syndrome

YES

NO

DON’T KNOW
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m. Gender of baby

YES

NO

DON’T KNOW

n. Autism

YES

NO

DON’T KNOW

o. Structure of brain

YES

NO

DON’T KNOW

13. Please circle the one answer that best describes your race/ethnicity, or fill in with the
appropriate response.
(A) African-American
(B) Hispanic
(C) Asian
(D) Caucasian
(E) Other ________________________
14. What is the highest grade you have completed?
(A) Some high school
(B) High school
(C) Some college
(D) Bachelor degree
(E) Post-graduate or professional degree
15. What is your household’s combined annual income?
(A) < $10,000
(B) $10,000-$25,000
(C) $25,000-$50,000
(D) $50,000-$75000
(E) $75,000-100,000
(F) >$100,000

Thank you for your time!
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APPENDIX B
The University of Texas Medical School – Houston
Knowledge and perception of Down syndrome and targeted ultrasound
Dear Potential Study Participant,
You are being invited to take part in a research study conducted by Ashley Henriksen and
Jennifer Hoskovec at the University of Texas Medical School Houston. We are interested in
determining what you think ultrasound can tell you about Down syndrome. Women have
different perceptions of the ultrasound and the capabilities of an ultrasound to detect Down
syndrome. A targeted ultrasound is a detailed ultrasound examination interpreted by a
Maternal Fetal Medicine Specialist. It is helpful for doctors and genetic counselors to know
what patients think about ultrasound.
Your decision to join this research study is voluntary. You may refuse to take part, or
choose to stop taking part at any time. Your decision about participation in this study or
answering questions will not change the care or services that are available to you now. This
research project has been reviewed and approved by the Committee for the Protection of
Human Subjects (CPHS) of the University of Texas Houston Health Science Center.
If you agree to participate in this study, you will be asked to complete a questionnaire before
your genetic counseling session. You will be asked about your age, race/ethnicity,
education, previous pregnancies, and questions about ultrasound and Down syndrome. The
questionnaire will take approximately 10-15 minutes to complete. Your responses will be
confidential and will be viewed only by the researchers involved in the study. After
completing the questionnaire, it will be placed in a sealed envelope for the investigators.
Although the results of this study will be useful for doctors, other health professionals, and
future pregnant women, there may be no direct benefit to you for participating in this study.
There are no known risks to you for participating in this study. You can choose not to take
part in this study at any time. If you decide to participate, it is very important that you
answer as honestly as you can to the questions that are asked. There are no additional costs
to you to participate in this study. No personal identifiers will be recorded for the purpose
of this research study.
If you have any questions regarding this research study, please contact Ashley Henriksen,
BS, or Jennifer Hoskovec, MS, CGC at (713) 500-6383. If you are willing to take part in
our study, please complete and return the questionnaire in the enclosed envelope to the front
desk personnel or genetic counselor.
Thank you very much for considering this invitation to participate in our study.
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